Literature DB >> 10503575

Progress toward the global interruption of wild poliovirus type 2 transmission, 1999.

.   

Abstract

Since 1988, when the World Health Assembly resolved to eradicate poliomyelitis globally by 2000, substantial progress has been made in attaining this goal: the Americas, the Pacific Rim, Europe, and central Asia appear to be polio-free. The remaining reservoirs where polio is endemic are confined to India and contiguous countries and to sub-Saharan Africa. In 1999, the recommended polio eradication strategies (i.e., achieving and maintaining high routine vaccination coverage with oral poliovirus vaccine [OPV]; conducting National Immunization Days [NIDs] to decrease rapid poliovirus circulation; establishing sensitive surveillance systems for polio cases and poliovirus; and carrying out mopping-up vaccination activities to eliminate poliovirus transmission) have been accelerated in most of the major reservoir countries. This report summarizes progress toward interrupting transmission of wild poliovirus type 2, which appears to be on the threshold of extinction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503575

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  10 in total

1.  Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.

Authors:  Chen-Fu Yang; Tary Naguib; Su-Ju Yang; Eman Nasr; Jaume Jorba; Nahed Ahmed; Ray Campagnoli; Harrie van der Avoort; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Mark Pallansch; Olen Kew
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

2.  Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.

Authors:  HaiBo Wang; Hui Cui; ZhenGrong Ding; Pian Ba; ShuangLi Zhu; Ning Wen; LiXin Hao; Jing Ning; Jie Zhang; De Yang; WenBo Xu; Yong Zhang; ChunXiang Fan; WenZhou Yu; XiaoFeng Liang; HuiMing Luo
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

3.  Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing.

Authors:  Juan Li; Zhujiazi Zhang; Herun Zhang; Maozhong Li; Xiaomei Li; Li Lu; Fang Huang; Jiang Wu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

4.  Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel.

Authors:  L M Shulman; Y Manor; R Handsher; F Delpeyroux; M J McDonough; T Halmut; I Silberstein; J Alfandari; J Quay; T Fisher; J Robinov; O M Kew; R Crainic; E Mendelson
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

5.  Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children.

Authors:  Markus Ringler; Georg Göbel; Johannes Möst; Kurt Weithaler
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

6.  Detection of vaccine-derived poliovirus circulation by environmental surveillance in the absence of clinical cases.

Authors:  John Kofi Odoom; Evangeline Obodai; Gifty Boateng; Stanley Diamenu; Keren Attiku; Patrick Avevor; Ewurabena Duker; Bismarck Boahene; Miriam Eshun; Emmanuel Gberbie; Joseph Kwadwo Larbi Opare
Journal:  Hum Vaccin Immunother       Date:  2021-01-30       Impact factor: 3.452

7.  Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009.

Authors:  Ondrej Mach; Harish Verma; Devendra W Khandait; Roland W Sutter; Patrick M O'Connor; Mark A Pallansch; Stephen L Cochi; Robert W Linkins; Susan Y Chu; Chris Wolff; Hamid S Jafari
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

8.  An outbreak of type π vaccine-derived poliovirus in Sichuan province, China: emergence and circulation in an under-immunized population.

Authors:  Hai-Bo Wang; Gang Fang; Wen-Zhou Yu; Fei Du; Chun-Xiang Fan; Qing-Lian Liu; Li-Xin Hao; Yu Liu; Jing-Shan Zheng; Zhi-Ying Qin; Wei Xia; Shi-Yue Zhang; Zun-Dong Yin; Qiong Jing; Yan-Xia Zhang; Rong-Na Huang; Ru-Pei Yang; Wen-Bin Tong; Qi Qi; Xu-Jing Guan; Yu-Lin Jing; Qian-Li Ma; Jin Wang; Xiao-Zhen Ma; Na Chen; Hong-Ru Zheng; Yin-Qiao Li; Chao Ma; Qi-Ru Su; Kathleen H Reilly; Hui-Ming Luo; Xian-Ping Wu; Ning Wen; Wei-Zhong Yang
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

9.  Enhanced surveillance of acute flaccid paralysis following importation of wild poliovirus in Xinjiang Uygur Autonomous Region, China.

Authors:  Ning Wen; Chun-Xiang Fan; Jian-Ping Fu; Jing Ning; Yi-Xin Ji; Hui-Ming Luo; Hua-Qing Wang; Shuang-Li Zhu; Wen-Zhou Yu; Hai-Bo Wang; Hui Zhu; Fu-Qiang Cui; De-Xin Li; Shi-Wen Wang; Wen-Bo Xu; Li-Xin Hao; Ling-Sheng Cao; Li Luo; Lu Han; Lei Cao; Wei Xia; Xin-Qi Wang; Kathleen H Reilly; Fuerhati Wushouer; Sha-Sha Mi; Wei-Zhong Yang; Li Li
Journal:  BMC Infect Dis       Date:  2014-02-27       Impact factor: 3.090

10.  Sero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.

Authors:  Hai-Bo Wang; Shuang-Li Zhu; Jing-Shan Zheng; Ai-Li Gou; Hui Cui; Yong Zhang; Gui-Jun Ning; Chun-Xiang Fan; Yuan-Sheng Chen; Ke-Li Li; Ping Yuan; Chao Ma; Jing Ma; Hui Zheng; Xin-Chun Fan; Xin-Lan Li; Hai-Shu Tang; Xiao-Lei Li; Fan Zhang; Dong-Mei Yan; Dong-Yan Wang; Zhi-Qiang Cui; Li-Ping Ren; Hui Zhu; Hui-Ling Wang; Xiao-Hong Jiang; Hong-Qiu An; Yang Liu; Jing Li; Wen-Bo Xu; Ning Wen; Ai-Qiang Xu; Hui-Ming Luo
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.